Full Text View
Tabular View
No Study Results Posted
Related Studies
MDs on Botox Utility (MOBILITY)
This study is ongoing, but not recruiting participants.
Study NCT00535938   Information provided by Allergan

First Received on September 25, 2007.   Last Updated on November 21, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Blepharospasm
Torticollis
Strabismus
Muscle Spasticity
More general conditions related to this trial
Central Nervous System Diseases
Cranial Nerve Diseases
Dyskinesias
Dystonia
Dystonic Disorders
Eye Diseases
Eyelid Diseases
Movement Disorders
Muscle Hypertonia
Muscular Diseases
Musculoskeletal Diseases
Nervous System Diseases
Neurologic Manifestations
Neuromuscular Manifestations
Ocular Motility Disorders
Signs and Symptoms
Interventions listed in this trial
botulinum toxin type A
Additional drug interventions recognized in this trial
Botulinum Toxins
Botulinum Toxins, Type A
More general drug interventions related to this trial
Anti-Dyskinesia Agents
Central Nervous System Agents
Neuromuscular Agents
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
Allergan


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services